Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | TAAR1 | Q96RJ0 | 4/20 | 0.44 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.41 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.41 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.39 |
| ▸ | DPP4 | P27487 | 2/20 | 0.39 |
| ▸ | F2 | P00734 | 1/20 | 0.39 |
| ▸ | MIF | P14174 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetone SCHEMBL28777513 | 0.89 | CYP2D6 (0.43) | TSHRCYP2D6LMNAALDH1A1 | |
| SCHEMBL498588 | 0.83 | TSHR (0.52) | TSHRTAAR1KDM4EADRA2AADRA2C | |
| SCHEMBL304645 | 0.83 | TSHR (0.52) | TSHRTAAR1KDM4EADRA2AADRA2C | |
| SCHEMBL306112 | 0.83 | TSHR (0.52) | TSHRTAAR1KDM4EADRA2AADRA2C | |
| SCHEMBL6283476 | 0.82 | TSHR (0.65) | TSHRTAAR1CYP2D6LMNADPP4 | |
| SCHEMBL9750479 | 0.81 | TSHR (0.50) | TSHRTAAR1KDM4EADRA2AADRA2C | |
| SCHEMBL3280292 | 0.79 | ADRA2A (0.54) | TSHRTAAR1AOC3KDM4EADRA2A | |
| SCHEMBL4778223 | 0.79 | LMNA (0.48) | TSHRAOC3KDM4EADRA2AADRA2C | |
| SCHEMBL11887151 | 0.79 | ADRA2A (0.54) | TSHRTAAR1AOC3KDM4EADRA2A | |
| Hydrochloric Acid SCHEMBL3284983 | 0.77 | ALDH1A1 (0.56) | TSHRTAAR1KDM4EADRA2AADRA2C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 54 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11214578-B2 | Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof | NORTHEASTERN UNIVERSITY (US) | 2022-01-04 | — | — | US | disclosed |
| CN-107417890-B | Composition, cured product, prepreg, and laminate | 日铁化学材料株式会社 | 2021-07-20 | — | — | CN | disclosed |
| US-20200287140-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2020-09-10 | — | — | US | disclosed |
| US-20200148696-A1 | Urea/Carbamates FAAH MAGL Or Dual FAAH/MAGL Inhibitors And Uses Thereof | NORTHEASTERN UNIVERSITY | 2020-05-14 | — | — | US | disclosed |
| US-10570146-B2 | Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof | NORTHEASTERN UNIVERSITY (US) | 2020-02-25 | — | — | US | disclosed |
| US-20170247387-A1 | UREA/CARBAMATES FAAH MAGL OR DUAL FAAH/MAGL INHIBITORS AND USES THEREOF | NORTHEASTERN UNIVERSITY | 2017-08-31 | — | — | US | disclosed |
| CN-106220486-A | A kind of synthetic method of high-load cyclamen aldehyde spice | 安徽华业香料股份有限公司 | 2016-12-14 | — | — | CN | disclosed |
| CN-106187719-A | The synthetic method of cyclamen aldehyde precursor p-isopropyl β chlorine α methylbenzene acrylic aldehyde | 安徽华业香料股份有限公司 | 2016-12-07 | — | — | CN | disclosed |
| US-20160122450-A1 | SYNTHESIS OF A SUBSTITUTED FURAN | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH (SG) | 2016-05-05 | — | — | US | disclosed |
| WO-2016014975-A2 | UREA/CARBAMATES FAAH MAGL OR DUAL FAAH/MAGL INHIBITORS AND USES THEREOF | NORTHEASTERN UNIVERSITY (US) | 2016-01-28 | — | — | WO | disclosed |
| EP-0250090-A2 | Storage stable latently curable acrylic formulations employing polymeric hydroperoxides | LOCTITE CORPORATION (US) | 1987-12-23 | — | — | EP | disclosed |
| US-4568761-A | Process for preparing tertiary aralkyl carbamates from tertiary aralkyl chlorides | AMERICAN CYANAMID COMPANY (US) | 1986-02-04 | — | — | US | disclosed |
| EP-0074008-B1 | PROCESS FOR PRODUCING ALPHA-ARYLALKANOIC ACID ESTERS | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1984-10-10 | — | — | EP | disclosed |
| US-4452746-A | TO MODIFY PROPERTIES OF HIGH MOLECULAR WEIGHT COMPOUNDS | NIPPON PAINT CO., LTD. (JP) | 1984-06-05 | — | — | US | disclosed |
| US-4433160-A | Process for producing α-arylalkanoic acid ester | TAISHO PHARMACEUTICAL COMPANY, LTD. (JP) | 1984-02-21 | — | — | US | disclosed |
| EP-0074008-A2 | Process for producing alpha-arylalkanoic acid esters | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1983-03-16 | — | — | EP | disclosed |
| US-4352748-A | Novel acyl-polyalkylindan compounds and the use thereof as a base for perfume, as well as perfume compositions | NAARDEN INTERNATIONAL N.V. (NL) | 1982-10-05 | — | — | US | disclosed |
| EP-0009077-B1 | SUBSTITUTED PHENYLPROPYL HALIDES, THEIR PREPARATION AND USE | BASF Aktiengesellschaft (DE) | 1981-09-30 | — | — | EP | disclosed |
| EP-0009683-A1 | Basic phenyl ethers, pharmaceutical compositions containing them and the preparation of these ethers and compositions | MERCK PATENT GmbH (DE) | 1980-04-16 | — | — | EP | disclosed |
| US-4196151-A | Process for producing β,γ-unsaturated aldehyde | NIPPON OIL AND FATS CO., LTD. (JP) | 1980-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11214578-B2 | Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof | FAAH, FAAH2, MGLL | TSHR 2828/4885TAAR1 537/4885AOC3 170/4885 |
| US-20200287140-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING THE SAME, AND AN ELECTRONIC DEVICE THEREOF | OR51E2, PIEZO1, OR10J3 | TSHR 4618/4885TAAR1 2842/4885AOC3 187/4885 |
| US-10570146-B2 | Urea/carbamates FAAH MAGL or dual FAAH/MAGL inhibitors and uses thereof | FAAH, FAAH2, MGLL | TSHR 2380/4885TAAR1 430/4885AOC3 628/4885 |
| US-20170247387-A1 | UREA/CARBAMATES FAAH MAGL OR DUAL FAAH/MAGL INHIBITORS AND USES THEREOF | FAAH, FAAH2, MGLL | TSHR 2518/4885TAAR1 718/4885AOC3 469/4885 |
| US-20160122450-A1 | SYNTHESIS OF A SUBSTITUTED FURAN | DCXR, PFAS, FUT6 | TSHR 2815/4885TAAR1 3296/4885AOC3 536/4885 |
| US-20200148696-A1 | Urea/Carbamates FAAH MAGL Or Dual FAAH/MAGL Inhibitors And Uses Thereof | FAAH, MGLL, FAAH2 | TSHR 2183/4885TAAR1 639/4885AOC3 402/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.